On November 7, Intuitive Surgical fell 3.05% in Regular Trading, trading at $454.36 per share, with turnover of $4.15 billion.
The latest identified catalyst is an event-driven mix: the market continued digesting the appointment of Aaron Martin to the board, while HSBC only nudged its price target to $392 from $391, a level still well below the broader analyst mean near $489.61, limiting incremental support for sentiment.
Background remains tied to the companys recent quarterly update. Intuitive Surgical reported third-quarter revenue of $3.049 billion and adjusted EPS of $3.00, both ahead of expectations, but it also tightened its outlook for robot-assisted procedure growth, reinforcing an ongoing market debate between stronger-than-expected results and moderating growth momentum.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments